In summary, our results indicate that KDM2B rapidly binds to the KSHV genome and reduces the level of activating histone marks at the promoter of lytic genes during de novo viral infection, which can contribute to the KDM2B-mediated inhibition of lytic genes thereby promoting the establishment and maintenance of KSHV latency. Here, KDM2B is linked to viral infectious disease.